These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3180338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of acyltransferase-mediated mutagenicity and nucleic acid binding of N-acetoxy-4-acetylaminobiphenyl by hepatic and bladder microsomes from rats and dogs.
    Swaminathan S, Hatcher JF.
    Environ Mol Mutagen; 1992; 20(1):61-72. PubMed ID: 1379179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species.
    Lower GM, Bryan GT.
    J Toxicol Environ Health; 1976 Jan; 1(3):421-32. PubMed ID: 1550
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of rat hepatic microsomal N,O-acyltransferases.
    Wang CY, Zukowski K, Lee MS, Sone T.
    Carcinogenesis; 1992 Nov; 13(11):2017-20. PubMed ID: 1423870
    [Abstract] [Full Text] [Related]

  • 6. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice.
    Lai CC, Miller EC, Miller JA, Liem A.
    Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346
    [Abstract] [Full Text] [Related]

  • 7. Acetylation of 2-aminofluorene derivatives by dog hepatic microsomes.
    Sone T, Zukowski K, Land SJ, King CM, Wang CY.
    Carcinogenesis; 1991 Oct; 12(10):1887-91. PubMed ID: 1934270
    [Abstract] [Full Text] [Related]

  • 8. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
    Aune T, Vanderslice RR, Croft JE, Dybing E, Bend JR, Philpot RM.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
    [Abstract] [Full Text] [Related]

  • 9. Repair synthesis of DNA induced by the urinary N-hydroxy metabolites of carcinogenic arylamines in urothelial cells of susceptible species.
    Wang CY, Morton KC, Lee MS.
    Cancer Res; 1985 Jan; 45(1):221-5. PubMed ID: 3965133
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin by guinea pig liver microsomal enzymes.
    Vaught JB, Glowinski IB, King CM.
    Carcinogenesis; 1985 Apr; 6(4):495-9. PubMed ID: 2859126
    [Abstract] [Full Text] [Related]

  • 11. Deacylation of N-arylformamides and N-arylacetamides by formamidase in rat liver.
    Ueda O, Kitamura S, Ohta S.
    Drug Metab Dispos; 2002 Dec; 30(12):1297-9. PubMed ID: 12433795
    [Abstract] [Full Text] [Related]

  • 12. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences.
    Graichen ME, Dent JG.
    Carcinogenesis; 1984 Jan; 5(1):23-8. PubMed ID: 6690083
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C, Batardy-Grégoire M, Roberfroid M.
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [Abstract] [Full Text] [Related]

  • 14. Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by N-hydroxy derivatives of carcinogenic arylamines.
    Wang CY, Yamada H, Morton KC, Zukowski K, Lee MS, King CM.
    Cancer Res; 1988 Aug 01; 48(15):4227-32. PubMed ID: 3390817
    [Abstract] [Full Text] [Related]

  • 15. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles.
    Smith BA, Springfield JR, Gutmann HR.
    Carcinogenesis; 1986 Mar 01; 7(3):405-11. PubMed ID: 3512117
    [Abstract] [Full Text] [Related]

  • 16. The deacetylation of N-arylacetamides in vitro.
    Gorrod JW.
    Biochem J; 1971 Jun 01; 123(2):10P-11P. PubMed ID: 5127327
    [No Abstract] [Full Text] [Related]

  • 17. Genetic variability in deacetylation of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in inbred strains of mice.
    Hultin TA, Weber WW.
    Carcinogenesis; 1987 Dec 01; 8(12):1939-41. PubMed ID: 3677317
    [Abstract] [Full Text] [Related]

  • 18. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ, Kadlubar FF.
    Carcinogenesis; 1986 Jun 01; 7(6):919-26. PubMed ID: 3708755
    [Abstract] [Full Text] [Related]

  • 19. Microsomal deacetylation of ring-hydroxylated 2-(acetylamino)fluorene isomers: effect of ring position and molecular mechanics considerations.
    Castañeda-Acosta J, Bounds PL, Winston GW.
    J Biochem Mol Toxicol; 1999 Jun 01; 13(5):279-86. PubMed ID: 10402562
    [Abstract] [Full Text] [Related]

  • 20. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl.
    van de Poll ML, van der Hulst DA, Tates AD, Meerman JH.
    Carcinogenesis; 1990 Feb 01; 11(2):333-9. PubMed ID: 2302760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.